Sign up to save your podcasts
Or
Share Recently Approved Drugs: Pembrolizumab for cHL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
More shows like ASCO Education
View all
Exchanges
979 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
497 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JCO Oncology Practice Podcast
18 Listeners
ASCO Daily News
57 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
298 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
WSJ Minute Briefing
673 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
ASCO Guidelines
44 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
NEJM AI Grand Rounds
57 Listeners
Two Onc Docs
189 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners